About this trial
This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 years and older.
Patients with a confirmed diagnosis of acute pulmonary embolism.
Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction.
Disqualifiers
Patients younger than 18 years.
Patients with incomplete clinical data.
Patients who did not undergo transthoracic echocardiography.
Trial population
Patients diagnosed as acute pulmonary embolism
Trial design
Cohort
Prospective
Treatments tested in this trial
Transthoracic Echocardiography
Other interventionTransthoracic echocardiography performed for assessment of right ventricular dysfunction in patients with acute pulmonary embolism.
Treatment groups
Trial outcomes
Primary outcomes
Right ventricular dysfunction as a prognostic marker in acute pulmonary embolism
To assess the prognostic value of right ventricular dysfunction detected by transthoracic echocardiography for risk stratification in patients with acute pulmonary embolism
Secondary outcomes
In-hospital adverse clinical outcomes
To evaluate the occurrence of in-hospital adverse clinical outcomes, including respiratory failure, hemodynamic instability, cardiac arrhythmias, intensive care unit admission, and mortality, and their association with right ventricular dysfunction in patients with acute pulmonary embolism
Sponsors and contacts
Click on the lead sponsor to view all of their trials.